Target intelligence / Profile preview

Lysozyme-like protein 2 (LYZL2)

Target
LYZL2
Molecular classification
Enzyme, Glycoside hydrolase family 22 (the canonical lysozyme family)
01

Overview

Lysozyme-like protein 2 (LYZL2) belongs to the glycoside hydrolase family 22, sharing significant structural similarity to classical c-type lysozymes but with notable functional divergence[1][6]. The protein is encoded on human chromosome 10 and is predominantly expressed in the male reproductive system, such as the testis and epididymis[3][5]. Unlike canonical lysozymes, which are potent antimicrobial enzymes found in saliva and other tissues, LYZL2 demonstrates altered or reduced catalytic activity due to amino acid substitutions in key active site residues[1][6]. Structurally, it retains the lysozyme fold and binding pockets, but evolutionary gene duplication and divergence have resulted in tissue-specific expression and putative roles in reproduction, possibly related to sperm physiology and interactions[5][1]. As of now, LYZL2 is not recognized as a clinically significant therapeutic target, nor is it the focus of any known pharmacological interventions or drug development studies[5][6]. Several aliases exist due to historical gene naming conventions and its similarity to other lysozyme paralogs.

Other names
Lysozyme-like protein 2LYZL2Lysozyme-2LYZD2lysozyme-like protein 2lysozyme D2lysozyme-2
02

Biological functions

Hydrolysis of glycosidic bonds in bacterial cell wall componentsPossible involvement in reproductive system (predominantly expressed in male reproductive tract)Potential immune function, though distinct from classic antimicrobial lysozymes
03

Disease associations

Possibly associated with hereditary systemic amyloidosis (as a lysozyme family member)No strong evidence yet for direct involvement in major diseases (e.g., cancer, cardiovascular disease, etc.)

Beyond the preview

Go deeper on Lysozyme-like protein 2 (LYZL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysozyme-like protein 2 (LYZL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call